JP2022551477A5 - - Google Patents

Info

Publication number
JP2022551477A5
JP2022551477A5 JP2022521355A JP2022521355A JP2022551477A5 JP 2022551477 A5 JP2022551477 A5 JP 2022551477A5 JP 2022521355 A JP2022521355 A JP 2022521355A JP 2022521355 A JP2022521355 A JP 2022521355A JP 2022551477 A5 JP2022551477 A5 JP 2022551477A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
pharmaceutical composition
ester
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022521355A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551477A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054857 external-priority patent/WO2021137913A2/en
Publication of JP2022551477A publication Critical patent/JP2022551477A/ja
Publication of JP2022551477A5 publication Critical patent/JP2022551477A5/ja
Priority to JP2025172129A priority Critical patent/JP2026027247A/ja
Pending legal-status Critical Current

Links

JP2022521355A 2019-10-08 2020-10-08 ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用 Pending JP2022551477A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025172129A JP2026027247A (ja) 2019-10-08 2025-10-10 ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962912165P 2019-10-08 2019-10-08
US62/912,165 2019-10-08
PCT/US2020/054857 WO2021137913A2 (en) 2019-10-08 2020-10-08 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025172129A Division JP2026027247A (ja) 2019-10-08 2025-10-10 ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用

Publications (2)

Publication Number Publication Date
JP2022551477A JP2022551477A (ja) 2022-12-09
JP2022551477A5 true JP2022551477A5 (https=) 2023-11-10

Family

ID=76686993

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022521355A Pending JP2022551477A (ja) 2019-10-08 2020-10-08 ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用
JP2025172129A Pending JP2026027247A (ja) 2019-10-08 2025-10-10 ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025172129A Pending JP2026027247A (ja) 2019-10-08 2025-10-10 ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用

Country Status (7)

Country Link
US (2) US20240165143A1 (https=)
EP (1) EP4040965A4 (https=)
JP (2) JP2022551477A (https=)
CN (2) CN118477090A (https=)
AU (1) AU2020418425A1 (https=)
CA (1) CA3153281A1 (https=)
WO (1) WO2021137913A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11312743B1 (en) * 2021-03-20 2022-04-26 Optimus Drugs Private Limited Process for molnupiravir
CN113929724B (zh) * 2021-11-02 2024-05-31 周雨恬 一种核苷类化合物及其药物组合物和用途
US20250282812A1 (en) * 2022-04-20 2025-09-11 Shanghai Institute Of Materia Medica , Chinese Academy Of Sciences Antiviral nucleoside analogue, and pharmaceutical composition and use thereof
WO2024123207A1 (ru) * 2022-12-08 2024-06-13 федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации 5'-о-(3-фенилпропионил)-n4-гидроксицитидин и его применение
WO2024123206A1 (ru) * 2022-12-08 2024-06-13 федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Способ получения 5',-о-(3-фенилпропионил)-n4-гидроксицитидина
WO2025014360A1 (en) * 2023-07-07 2025-01-16 Erasmus University Medical Center Rotterdam Guanosine nucleotide analogs for use in preventing and/or treating hepatitis e virus infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710492A (en) * 1986-06-23 1987-12-01 Yale University 3'-azido-2',3'-dideoxy-5-halouridine and its use in treating patients infected with retroviruses
EP1674104A1 (en) * 2004-12-24 2006-06-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Uridine derivatives as antiviral drugs against a flaviviridae, especially HCV
JP6165848B2 (ja) * 2012-05-22 2017-07-19 イデニク ファーマシューティカルズ エルエルシー 肝疾患のためのｄ−アミノ酸化合物
AU2014302711A1 (en) * 2013-06-26 2015-12-10 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2015054465A1 (en) * 2013-10-11 2015-04-16 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
HUE051986T2 (hu) * 2014-06-24 2021-04-28 Janssen Biopharma Inc Helyettesített nukleozidok, nukleotidek és analógjaik virális fertõzés kezelésére való alkalmazásra
KR20200140274A (ko) * 2018-03-07 2020-12-15 에모리 유니버시티 4'-할로겐 함유 뉴클레오티드 및 뉴클레오시드 치료 조성물 및 이와 관련된 용도

Similar Documents

Publication Publication Date Title
JP2022551477A5 (https=)
JP2023512666A5 (https=)
ES2985995T3 (es) Compuestos y métodos para el tratamiento de infecciones víricas
US12226429B2 (en) Highly active compounds against COVID-19
US11660307B2 (en) Methods for treating SARS CoV-2 infections
CN115362004B (zh) 1’-氰基取代的碳核苷类似物的吸入制剂
CN115715190B (zh) 用于治疗病毒感染的瑞德西韦和瑞德西韦类似物、溶液剂以及纳米粒子、脂质体和微粒组合物
ES2241008T3 (es) Profarmacos de benzamidoxina y uso de los mismos para el tratamiento de la neumonia.
TWI867455B (zh) 用於治療病毒感染的化合物及方法
US20240043466A1 (en) Solid forms of a nucleoside analogue and uses thereof
US20240051962A1 (en) Solid forms of a nucleoside analogue and uses thereof
TW202525811A (zh) 用於治療病毒感染的化合物及方法
HRP20100065T1 (hr) Derivati azapeptida kao inhibitori hiv proteaze
MX342062B (es) Composicion farmaceutica para administracion oral.
US20250109157A1 (en) Compounds and methods for treatment of viral infections
US12516081B2 (en) Anti-viral compounds and methods of use
HK40096728B (zh) 用於治疗病毒感染的化合物和方法
HK40096728A (zh) 用於治疗病毒感染的化合物和方法
HK40113783A (zh) 用於治疗病毒感染的化合物和方法
CN118786127A (zh) 用于治疗病毒感染的化合物和方法
HK40084723A (en) Inhalation formulations of 1’-cyano substituted carbanucleoside analogs